Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)
This study has been terminated.
Study NCT00151736
Information provided by Teva Pharmaceutical Industries
First Received on September 7, 2005.
Last Updated on June 8, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
